Metraipolis › archive › dc_79ffec4ebe71

Recent advances in biomarkers for efficacy assessment in allergen-specific immunotherapy — Europe PMC PMID:42325930

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42325930
DOI: 10.3389/falgy.2026.1793591
License (as archived): solo-consultazione
Archived: 2026-10-31T20:18:36.558Z
SHA-256 of the archived text: 599c63d127f0d2d1869a98ef0c42ab6a57bffe27fcdd20f4085379675f807c36
Stable URL of this page: https://metraipolis.com/documento/dc_79ffec4ebe71

How to cite

Recent advances in biomarkers for efficacy assessment in allergen-specific immunotherapy — Europe PMC PMID:42325930 — Europe PMC (en), https://europepmc.org/article/MED/42325930 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_79ffec4ebe71 (Metraipolis archive dc_79ffec4ebe71, sha256 599c63d127f0d2d1869a98ef0c42ab6a57bffe27fcdd20f4085379675f807c36)

BibTeX

@misc{dc79ffec4ebe71,
  title = {Recent advances in biomarkers for efficacy assessment in allergen-specific immunotherapy — Europe PMC PMID:42325930},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42325930},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_79ffec4ebe71; sha256 599c63d127f0d2d1869a98ef0c42ab6a57bffe27fcdd20f4085379675f807c36},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42325930. Agents can read the archived copy with the MCP tool read_document.